Skip to main content
Top
Published in: AIDS and Behavior 5/2020

01-05-2020 | Sexually Transmitted Infection | Original Paper

PrEP Use and Sexually Transmitted Infections Are Not Associated Longitudinally in a Cohort Study of Young Men Who Have Sex with Men and Transgender Women in Chicago

Authors: Ethan Morgan, Christina Dyar, Michael E. Newcomb, Richard T. D’Aquila, Brian Mustanski

Published in: AIDS and Behavior | Issue 5/2020

Login to get access

Abstract

Our goal was to understand whether PrEP users are at increased risk for STIs, a key target in prevention efforts aimed at disrupting the spread of STIs and likely downstream HIV infection risk. Data were collected as part of RADAR, a cohort study of young men who have sex with men and transgender women (YMSM/TW) (aged 16–29) in Chicago. Longitudinal lagged regression models were utilized to assess the relationship between PrEP use and odds of rectal STI acquisition. Mediation models were also utilized to consider the potential pathway between PrEP use, condomless anal sex (CAS), and rectal STI. One hundred eighty-seven (16.2%) participants had a rectal STI at baseline. In both cross-sectional and longitudinal models, no significant association was observed between PrEP use and STI. In mediation models, PrEP use was significantly associated with increased CAS, however, CAS was not associated with STI status. We demonstrated that, overall, PrEP use was not associated with STIs among YMSM/TW but did observe that PrEP users were more likely to report increased participation in CAS at the subsequent study visit.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2015. Atlanta: US Department of Health and Human Services; 2016. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2015. Atlanta: US Department of Health and Human Services; 2016.
4.
go back to reference Schillinger J. The intersection of PrEP and sexually transmitted infections. Conference on Retroviruses and Opportunisitic Infections (CROI); 2018; Boston, MA; 2018. Schillinger J. The intersection of PrEP and sexually transmitted infections. Conference on Retroviruses and Opportunisitic Infections (CROI); 2018; Boston, MA; 2018.
5.
go back to reference Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Eng J Med. 2010;363(27):2587–99.CrossRef Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Eng J Med. 2010;363(27):2587–99.CrossRef
6.
go back to reference Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251–2.CrossRef Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251–2.CrossRef
7.
go back to reference Harawa NT, Holloway IW, Leibowitz A, et al. Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition. AIDS. 2017;31(5):739–40.CrossRef Harawa NT, Holloway IW, Leibowitz A, et al. Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition. AIDS. 2017;31(5):739–40.CrossRef
8.
go back to reference Montanto M, Dombrowksi JC, Barbee LA, Golden M, Khosropour C. Changes in sexual behavior and STI diagnoses among MSM using PrEP in Seattle, WA. Conference on Retroviruses and Opportunisitic Infections (CROI); 2017; Seattle, WA; 2017. Montanto M, Dombrowksi JC, Barbee LA, Golden M, Khosropour C. Changes in sexual behavior and STI diagnoses among MSM using PrEP in Seattle, WA. Conference on Retroviruses and Opportunisitic Infections (CROI); 2017; Seattle, WA; 2017.
9.
go back to reference Centers for Disease Control and Prevention. Reported STDs in the United States 2014 national data for chlamydia, gonorrhea, and syphilis. Atlanta: CDC; 2015. Centers for Disease Control and Prevention. Reported STDs in the United States 2014 national data for chlamydia, gonorrhea, and syphilis. Atlanta: CDC; 2015.
10.
go back to reference Paz-Bailey G, Mendoza M, Finlayson T, et al. Trends in condom use among men who have sex with men in the United States: the role of antiretroviral therapy and seroadaptive strategies. AIDS. 2016;30:1985–90.CrossRef Paz-Bailey G, Mendoza M, Finlayson T, et al. Trends in condom use among men who have sex with men in the United States: the role of antiretroviral therapy and seroadaptive strategies. AIDS. 2016;30:1985–90.CrossRef
11.
go back to reference Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548–55.CrossRef Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548–55.CrossRef
12.
go back to reference Newcomb ME, Moran K, Feinstein BA, Forscher E, Mustanski B. Pre-exposure prophylaxis (PrEP) use and condomless anal sex: evidence of risk compensation in a cohort of young men who have sex with men. J Acquir Immune Defic Syndr. 2018;77(4):358–64.CrossRef Newcomb ME, Moran K, Feinstein BA, Forscher E, Mustanski B. Pre-exposure prophylaxis (PrEP) use and condomless anal sex: evidence of risk compensation in a cohort of young men who have sex with men. J Acquir Immune Defic Syndr. 2018;77(4):358–64.CrossRef
13.
go back to reference Nguyen VK, Greenwald ZR, Trottier H, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 2018;32(4):523–30.PubMed Nguyen VK, Greenwald ZR, Trottier H, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 2018;32(4):523–30.PubMed
14.
go back to reference Traeger M, Asselin J, Price B, et al. Changes, patterns and predictors of sexually transmitted infections in gay and bisexual men using PrEP—interim analysis from the PrEPX study. International AIDS Society (IAS); 2018; Amsterdam, Netherlands; 2018. Traeger M, Asselin J, Price B, et al. Changes, patterns and predictors of sexually transmitted infections in gay and bisexual men using PrEP—interim analysis from the PrEPX study. International AIDS Society (IAS); 2018; Amsterdam, Netherlands; 2018.
15.
go back to reference Hendershot CS, Magnan RE, Bryan AD. Associations of marijuana use and sex-related marijuana expectancies with HIV/STD risk behavior in high-risk adolescents. Psychol Addict Behav. 2010;24(3):404–14.CrossRef Hendershot CS, Magnan RE, Bryan AD. Associations of marijuana use and sex-related marijuana expectancies with HIV/STD risk behavior in high-risk adolescents. Psychol Addict Behav. 2010;24(3):404–14.CrossRef
16.
go back to reference Kirkcaldy RD, Zaidi A, Hook EW 3rd, et al. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005–2010. Ann Intern Med. 2013;158(5 Pt 1):321–8.CrossRef Kirkcaldy RD, Zaidi A, Hook EW 3rd, et al. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005–2010. Ann Intern Med. 2013;158(5 Pt 1):321–8.CrossRef
17.
go back to reference Brewer TH, Schillinger J, Lewis FM, et al. Infectious syphilis among adolescent and young adult men: implications for human immunodeficiency virus transmission and public health interventions. Sex Transm Dis. 2011;38(5):367–71.CrossRef Brewer TH, Schillinger J, Lewis FM, et al. Infectious syphilis among adolescent and young adult men: implications for human immunodeficiency virus transmission and public health interventions. Sex Transm Dis. 2011;38(5):367–71.CrossRef
18.
go back to reference Hyman MS, Bernstein KT, Raymond H, Kohn R, Klausner JD. Racial/ethnic and sexual behavior disparities in rates of sexually transmitted infections, San Francisco, 1999–2008. BMC Public Health. 2010;10:315.CrossRef Hyman MS, Bernstein KT, Raymond H, Kohn R, Klausner JD. Racial/ethnic and sexual behavior disparities in rates of sexually transmitted infections, San Francisco, 1999–2008. BMC Public Health. 2010;10:315.CrossRef
19.
go back to reference Mustanski B, Feinstein BA, Madkins K, Sullivan P, Swann G. Prevalence and risk factors for rectal and urethral sexually transmitted infections from self-collected samples among young men who have sex with men participating in the Keep It Up! 2.0 randomized controlled trial. Sex Transm Dis. 2017;44(8):483–8.CrossRef Mustanski B, Feinstein BA, Madkins K, Sullivan P, Swann G. Prevalence and risk factors for rectal and urethral sexually transmitted infections from self-collected samples among young men who have sex with men participating in the Keep It Up! 2.0 randomized controlled trial. Sex Transm Dis. 2017;44(8):483–8.CrossRef
20.
go back to reference Millett GA, Flores SA, Peterson JL, Bakeman R. Explaining disparities in HIV infection among black and white men who have sex with men: a meta-analysis of HIV risk behaviors. AIDS. 2007;21(15):2083–91.CrossRef Millett GA, Flores SA, Peterson JL, Bakeman R. Explaining disparities in HIV infection among black and white men who have sex with men: a meta-analysis of HIV risk behaviors. AIDS. 2007;21(15):2083–91.CrossRef
21.
go back to reference Newcomb ME, Mustanski B. Racial differences in same-race partnering and the effects of sexual partnership characteristics on HIV Risk in MSM: a prospective sexual diary study. J Acquir Immune Defic Syndr. 2013;62(3):329–33.CrossRef Newcomb ME, Mustanski B. Racial differences in same-race partnering and the effects of sexual partnership characteristics on HIV Risk in MSM: a prospective sexual diary study. J Acquir Immune Defic Syndr. 2013;62(3):329–33.CrossRef
23.
go back to reference Hall H, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.CrossRef Hall H, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.CrossRef
24.
go back to reference Boyadzhyan B, Yashina T, Yatabe JH, Patnaik M, Hill CS. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2004;42(7):3089–93.CrossRef Boyadzhyan B, Yashina T, Yatabe JH, Patnaik M, Hill CS. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2004;42(7):3089–93.CrossRef
25.
go back to reference Swann G, Newcomb M, Mustanski BS. Validation of the HIV risk assessment of sexual partnerships (H-RASP): comparison to a 2-month prospective diary study. Arch Sex Behav. 2017;47(1):121–31.CrossRef Swann G, Newcomb M, Mustanski BS. Validation of the HIV risk assessment of sexual partnerships (H-RASP): comparison to a 2-month prospective diary study. Arch Sex Behav. 2017;47(1):121–31.CrossRef
26.
go back to reference Mustanski BS, Starks T, Newcomb M. Methods for the design and analysis of relationship and partner effects on sexual health. Arch Sex Behav. 2014;43(1):21–33.CrossRef Mustanski BS, Starks T, Newcomb M. Methods for the design and analysis of relationship and partner effects on sexual health. Arch Sex Behav. 2014;43(1):21–33.CrossRef
27.
go back to reference Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. AnImproved brief measure of cannabis misuse: the cannabis use disorders identification test-revised (CUDIT-R). Drug Alcohol Depend. 2010;110:137–43.CrossRef Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. AnImproved brief measure of cannabis misuse: the cannabis use disorders identification test-revised (CUDIT-R). Drug Alcohol Depend. 2010;110:137–43.CrossRef
28.
go back to reference Babor T, Higgins-Biddle J, Saunders J, Monteiro M. AUDIT, the Alcohol Use Disorders Identification test: guidelines for use in primary health care. Geneva: World Health Organization (WHO); 2001. Babor T, Higgins-Biddle J, Saunders J, Monteiro M. AUDIT, the Alcohol Use Disorders Identification test: guidelines for use in primary health care. Geneva: World Health Organization (WHO); 2001.
29.
go back to reference Traeger MW, Schroeder SE, Wright EJ, et al. Effects of pre-exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676–86.CrossRef Traeger MW, Schroeder SE, Wright EJ, et al. Effects of pre-exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676–86.CrossRef
30.
go back to reference Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of gonorrhea and chlamydia following HIV preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65(5):712–8.CrossRef Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of gonorrhea and chlamydia following HIV preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65(5):712–8.CrossRef
31.
go back to reference Pathela P, Braunstein SL, Schillinger JA, Shepard C, Sweeney M, Blank S. Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York City. J Acquir Immune Defic Syndr. 2011;58(4):408–16.CrossRef Pathela P, Braunstein SL, Schillinger JA, Shepard C, Sweeney M, Blank S. Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York City. J Acquir Immune Defic Syndr. 2011;58(4):408–16.CrossRef
Metadata
Title
PrEP Use and Sexually Transmitted Infections Are Not Associated Longitudinally in a Cohort Study of Young Men Who Have Sex with Men and Transgender Women in Chicago
Authors
Ethan Morgan
Christina Dyar
Michael E. Newcomb
Richard T. D’Aquila
Brian Mustanski
Publication date
01-05-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02664-9

Other articles of this Issue 5/2020

AIDS and Behavior 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.